ArticleScientific reports2023

Production of neutralizing antibody fragment variants in the cytoplasm of E. coli for rapid screening: SARS-CoV-2 a case study.

Aatir A Tungekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.